US HB5958 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on October 13 2023 - 25% progression
Action: 2023-10-25 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 13 2023 - 25% progression
Action: 2023-10-25 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Title
Drug-price Transparency for Consumers Act of 2023
Sponsors
| Rep. Abigail Spanberger [D-VA] | Rep. Zachary Nunn [R-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-10-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-10-13 | House | Introduced in House |
Same As/Similar To
SB1250 (Same As) 2023-04-20 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/5958/all-info |
| Text | https://www.congress.gov/118/bills/hr5958/BILLS-118hr5958ih.pdf |
